Murphy Keith has filed 6 insider transactions across 2 companies since November 2023.
Most recent transaction: a grant/award of 15000 shares of VivoSim Labs, INC. ($VIVS) on January 27, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 27, 2026 | VivoSim Labs, INC. | $VIVS | Murphy Keith | EXECUTIVE CHAIRMAN | A | Common Stock | 15000 | $0.00 | 26,053.0000 | 2,607,962 | 135.71% | 0.58% |
| April 30, 2025 | Matinas BioPharma Holdings, Inc. | $MTNB | Murphy Keith | Director | A | Stock Option (right to Buy) | 11600 | $0.00 | 11,600.0000 | 5,086,985 | 9999.99% | 0.23% |
| Aug. 7, 2024 | VivoSim Labs, INC. | $VIVS | Murphy Keith | EXECUTIVE CHAIRMAN | A | Common Stock | 19607 | $0.00 | 132,641.0000 | 839,814 | 17.35% | 2.33% |
| Aug. 5, 2024 | VivoSim Labs, INC. | $VIVS | Murphy Keith | EXECUTIVE CHAIRMAN | A | Options (right to buy) | 574923 | $0.00 | 574,923.0000 | 839,814 | 9999.99% | 68.46% |
| Aug. 5, 2024 | VivoSim Labs, INC. | $VIVS | Murphy Keith | EXECUTIVE CHAIRMAN | A | Options (right to buy) | 143731 | $0.00 | 143,731.0000 | 839,814 | 9999.99% | 17.12% |
| Nov. 17, 2023 | VivoSim Labs, INC. | $VIVS | Murphy Keith | Executive Chairman | A | Common Stock | 19607 | $0.00 | 113,034.0000 | 0 | 20.99% | 0.00% |